NCT04022473View on ClinicalTrials.gov

Study to Compare GI Tolerability Following Oral Administration of Bafiertam™ or Tecfidera to Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

July 7, 2019

Primary Completion Date

October 19, 2019

Study Completion Date

October 19, 2019

Conditions
Multiple Sclerosis
Interventions
DRUG

Bafiertam

Over-encapsulated capsule to mask treatment

DRUG

Tecfidera

Over-encapsulated capsule to mask treatment

Trial Locations (1)

65201

BioPharma Services, Inc., Columbia

Sponsors
All Listed Sponsors
lead

Banner Life Sciences LLC

INDUSTRY